Ankasa Regenerative Therapeutics, Inc. is a for-profit biotechnology company headquartered in South San Francisco, California.
Subscribe to see Ankasa Regenerative Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ankasa Regenerative Therapeutics, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $6M in September 2020. Xcout tracks 3 named people at Ankasa Regenerative Therapeutics, Inc., including Gloria Matthews (Chief Medical Officer of Ankasa).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $6M | — | |
| SEC Form D filing | $9.5M | — | |
| Grant | $19M | 6 named | |
| Series A | $17M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Ankasa Regenerative Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Rezo Therapeutics, Inc. is a biotechnology company headquartered in South San Francisco, California, that integrates proteomics, genetics, and structural biology for drug discovery and development.
Marea Therapeutics is a biotechnology research company headquartered in South San Francisco, California. The company focuses on developing novel therapeutics within the biopharma sector.
NewLimit, Inc. is a for-profit company headquartered in South San Francisco, California, operating in the biotechnology or life sciences sector. The firm engages in ongoing research and scientific updates from its California headquarters.
ResNovas Therapeutics is a biotechnology and therapeutics company headquartered in Alameda, California, operating within the San Francisco Bay Area.
Antiva Biosciences, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. The firm focuses on biotechnology research and developing treatments for viral infections and precancerous conditions.
Link Cell Therapies Inc. is a platform biotechnology company maintaining its headquarters in South San Francisco, California. The company develops novel agents targeting hematologic and related diseases.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Ankasa Regenerative Therapeutics, Inc.? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.